Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · IEX Real-Time Price · USD
13.32
-0.93 (-6.53%)
At close: Mar 28, 2024, 4:00 PM
13.98
+0.66 (4.95%)
After-hours: Mar 28, 2024, 7:45 PM EDT
Solid Biosciences Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Solid Biosciences stock have an average target of 18.14, with a low estimate of 5.00 and a high estimate of 40. The average target predicts an increase of 36.19% from the current stock price of 13.32.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SLDB stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 1 | 1 | 1 | 3 |
Buy | 2 | 2 | 1 | 1 | 1 | 4 |
Hold | 3 | 3 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 5 | 2 | 2 | 2 | 7 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
William Blair | William Blair | Buy Initiates $40 | Buy | Initiates | $40 | +200.30% | Mar 28, 2024 |
Barclays | Barclays | Buy Maintains $8 → $21 | Buy | Maintains | $8 → $21 | +57.66% | Mar 18, 2024 |
Citigroup | Citigroup | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +20.12% | Mar 15, 2024 |
Piper Sandler | Piper Sandler | Hold → Buy Upgrades $8 → $20 | Hold → Buy | Upgrades | $8 → $20 | +50.15% | Mar 14, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +20.12% | Mar 14, 2024 |
Financial Forecast
Revenue This Year
3.59M
Revenue Next Year
n/a
from 3.59M
EPS This Year
-3.40
from -4.83
EPS Next Year
-2.59
from -3.40
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 18.5M | n/a | n/a | n/a | 64.6M |
Avg | 3.6M | n/a | n/a | n/a | 31.4M |
Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
EPS Forecast
EPS | 2024 | 2025 |
---|---|---|
High | -1.58 | -2.09 |
Avg | -3.40 | -2.59 |
Low | -5.43 | -3.33 |
EPS Growth
EPS Growth | 2024 | 2025 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.